Top compounds associated with response to ASXL2


Feature Type Standardized
Nominal ANOVA
mRNA BMS-754807 FIMM pan-cancer AAC 0.3 0.03
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.069 0.04
mRNA TAE684 CTRPv2 pan-cancer AAC 0.075 0.04
mRNA Crizotinib CTRPv2 pan-cancer AAC 0.069 0.04
mRNA Methotrexate FIMM pan-cancer AAC 0.3 0.04
mRNA IPA-3 GDSC1000 pan-cancer AAC 0.071 0.04
mRNA Vinblastine GDSC1000 pan-cancer AAC 0.074 0.04
mRNA CR-1-31B CTRPv2 pan-cancer AAC 0.068 0.04
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.074 0.04
mRNA JQ-1 CTRPv2 pan-cancer AAC 0.065 0.04
Download CSV